Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".

× No keyword cloud information.

14 in total

Review 1. Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.

Authors: Sascha Meyer Dos Santos; Sebastian Harder
Journal: Drug Saf Date: 2014-05 Impact factor: 5.606

2. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.

Authors: Syed Mahamad; Hina Chaudhry; Rosane Nisenbaum; Amanda McFarlan; Sandro Rizoli; Alun Ackery; Michelle Sholzberg
Journal: J Thromb Thrombolysis Date: 2019-02 Impact factor: 2.300

Review 3. [New anticoagulants for stroke prevention in atrial fibrillation].

Authors: H C Diener; K Hajjar; B Frank; M Perrey
Journal: Herz Date: 2012-06 Impact factor: 1.443

4. Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.

Authors: E Chaussade; O Hanon; C Boully; F Labourée; L Caillard; G Gerotziafas; J-S Vidal; I Elalamy
Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075

Review 5. Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.

Authors: Virginie Siguret; Isabelle Gouin-Thibault; Pascale Gaussem; Eric Pautas
Journal: Drugs Aging Date: 2013-09 Impact factor: 3.923

6. Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry.

Authors: Georgios Tsivgoulis; Christos Krogias; Kara A Sands; Vijay K Sharma; Aristeidis H Katsanos; Konstantinos Vadikolias; Sokratis G Papageorgiou; Ioannis Heliopoulos; Harn Shiue; Athina Mitsoglou; Chrissoula Liantinioti; Dimitrios Athanasiadis; Sotirios Giannopoulos; Charitomeni Piperidou; Konstantinos Voumvourakis; Andrei V Alexandrov
Journal: Ther Adv Neurol Disord Date: 2014-05 Impact factor: 6.570

New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".

Review 1. Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.

2. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.

Review 3. [New anticoagulants for stroke prevention in atrial fibrillation].

4. Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.

Review 5. Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.

6. Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry.

Review 7. Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.

Review 8. Impact of prescribed medications on patient safety in older people.

9. Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?

10. Concerns regarding the use of dabigatran for stroke prevention in atrial fibrillation.